Medicare is spending far less than expected on new Alzheimer’s drugs www.statnews.com/2026/05/11/m... via @statnews.com @bobjherman.bsky.social
www.statnews.com
Adoption has been slow with new Alzheimer’s drugs because the treatments are complicated to administer and the benefits are uncertain.
Charles Piller